Technical Analysis for PRTG - Portage Biotech Inc.

Grade Last Price % Change Price Change
C 29.8 0.00% 0.00
PRTG closed unchanged on Friday, April 9, 2021, on 45 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical PRTG trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish -6.17%
Multiple of Ten Bullish Other -6.17%
Outside Day Range Expansion -6.17%
Older End-of-Day Signals for PRTG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits 1 day ago
Down 2 % 2 days ago
Down 1% 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Portage Biotech Inc. Description

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Solid Tumors Immune System Antibodies Interferon Biotechnology Products Acute Kidney Injury

Is PRTG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.5
52 Week Low 27.0775
Average Volume 13,195
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 31.10
10-Day Moving Average 29.14
Average True Range 2.73
ADX 19.29
+DI 17.93
-DI 18.49
Chandelier Exit (Long, 3 ATRs ) 27.82
Chandelier Exit (Short, 3 ATRs ) 35.25
Upper Bollinger Band 35.83
Lower Bollinger Band 26.37
Percent B (%b) 0.36
BandWidth 30.40
MACD Line -1.18
MACD Signal Line -1.20
MACD Histogram 0.0141
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.00
Resistance 3 (R3) 32.03 31.31 31.64
Resistance 2 (R2) 31.31 30.75 31.30 31.51
Resistance 1 (R1) 30.56 30.40 30.20 30.53 31.39
Pivot Point 29.84 29.84 29.66 29.83 29.84
Support 1 (S1) 29.09 29.28 28.73 29.07 28.21
Support 2 (S2) 28.37 28.93 28.36 28.09
Support 3 (S3) 27.62 28.37 27.96
Support 4 (S4) 27.60